Application 203564
- Type
- ANDA
- Sponsor
- LANNETT CO INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LAMIVUDINE | LAMIVUDINE | SOLUTION;ORAL | 10MG/ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 10135-605 | Lamivudine | Lamivudine | Marlex Pharmaceuticals Inc | ANDA | Current |
| 54838-566 | Lamivudine | Lamivudine | Lannett Company, Inc. | ANDA | Current |
| 54838-566 | Lamivudine | Lamivudine | Lannett Company, Inc. | ANDA | Current |
| 54838-566 | Lamivudine | Lamivudine | Lannett Company, Inc. | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 32441 | ORIG | 2014-11-05 |